Comments

Insmed Stock Price, Quotes and Forecasts

Q: What sector and industry does Insmed (INSM) operate in?

Insmed is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

INSMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$102.68

3.223.24%

At close: -

$102.40

-0.28-0.27%

After Hours: Jun 20, 6:22 PM EDT

Insmed (INSM) Forecast

News Earnings Insmed (INSM) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Insmed Stock Price, Quotes and Forecasts | NASDAQ:INSM | Benzinga

Explore Insmed stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INSM.

Open	$100.27
Close	$102.68
Volume / Avg.	4.67M / 2.89M
Day Range	$99.02 - $102.81
52 Wk Range	60.40 - 102.00
Market Cap	$19.45B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	79
Short Interest	10.3%
Days to Cover	7.27

Recent News

Russell Rebalance: 3 Stocks Ready to Move Higher

Investors pay close attention to the quarterly rebalancing of the S&P 500 index for good reason. First, the stocks in the S&P 500 make up approximately 80% of the total U.S. equity market. Second, when a stock

MarketBeat

Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?

Top 10 large-cap stocks with biggest gains last week: INSM, CRCL, ORCL, ASTS, SAIL, VG, TEM, CASY, EQNR, HAL. Have you invested in them?

Mohit Manghnani

Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast

BofA raises Insmed price target to $109 after strong TPIP data and flags FDA decision on brensocatib as a near-term share catalyst.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$100.27
Close	$102.68
Volume / Avg.	4.67M / 2.89M
Day Range	$99.02 - $102.81
52 Wk Range	60.40 - 102.00
Market Cap	$19.45B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	79
Short Interest	10.3%
Days to Cover	7.27

About

Sector

Healthcare

Industry

N/A

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Insmed (INSM) stock?

You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.

View our list of the best stock brokerages

Who are Insmed (INSM) competitors?

There are no as such competitors for Insmed.

What is the forecast, or price target, for Insmed (INSM) stock?

Insmed has a consensus price target of $96.21.

What is the current price for Insmed (INSM)?

The stock price for Insmed (NASDAQ: INSM) is $102.4 last updated June 20, 2025 at 6:22 PM EDT.

Does Insmed (INSM) pay a dividend?

There are no upcoming dividends for Insmed.

When is Insmed (NASDAQ:INSM) reporting earnings?

Insmed’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Insmed (INSM) going to split?

There is no upcoming split for Insmed.

What sector and industry does Insmed (INSM) operate in?

Insmed is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.